215 related articles for article (PubMed ID: 34965173)
1. Identification of HnRNPC as a novel Tau exon 10 splicing factor using RNA antisense purification mass spectrometry.
Xing S; Wang J; Wu R; Hefti MM; Crary JF; Lu Y
RNA Biol; 2022; 19(1):104-116. PubMed ID: 34965173
[TBL] [Abstract][Full Text] [Related]
2. RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion.
Kar A; Havlioglu N; Tarn WY; Wu JY
J Biol Chem; 2006 Aug; 281(34):24479-88. PubMed ID: 16777844
[TBL] [Abstract][Full Text] [Related]
3. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
Yu Q; Guo J; Zhou J
J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
Zhou J; Yu Q; Zou T
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
[TBL] [Abstract][Full Text] [Related]
5. PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.
Ray P; Kar A; Fushimi K; Havlioglu N; Chen X; Wu JY
J Mol Neurosci; 2011 Nov; 45(3):453-66. PubMed ID: 21881826
[TBL] [Abstract][Full Text] [Related]
6. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.
Bowles KR; Pugh DA; Oja LM; Jadow BM; Farrell K; Whitney K; Sharma A; Cherry JD; Raj T; Pereira AC; Crary JF; Goate AM
Acta Neuropathol; 2022 Feb; 143(2):225-243. PubMed ID: 34874463
[TBL] [Abstract][Full Text] [Related]
9. RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing.
Ong AAL; Tan J; Bhadra M; Dezanet C; Patil KM; Chong MS; Kierzek R; Decout JL; Roca X; Chen G
Molecules; 2019 Aug; 24(16):. PubMed ID: 31434312
[TBL] [Abstract][Full Text] [Related]
10. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A.
Qian W; Liang H; Shi J; Jin N; Grundke-Iqbal I; Iqbal K; Gong CX; Liu F
Nucleic Acids Res; 2011 Aug; 39(14):6161-71. PubMed ID: 21470964
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing.
Donahue CP; Muratore C; Wu JY; Kosik KS; Wolfe MS
J Biol Chem; 2006 Aug; 281(33):23302-6. PubMed ID: 16782711
[TBL] [Abstract][Full Text] [Related]
13. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
[TBL] [Abstract][Full Text] [Related]
14. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
Wang Y; Wang J; Gao L; Stamm S; Andreadis A
Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
[TBL] [Abstract][Full Text] [Related]
15. hnRNP A1 Regulates Alternative Splicing of Tau Exon 10 by Targeting 3' Splice Sites.
Liu Y; Kim D; Choi N; Oh J; Ha J; Zhou J; Zheng X; Shen H
Cells; 2020 Apr; 9(4):. PubMed ID: 32290247
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.
Wang Y; Gao L; Tse SW; Andreadis A
Gene; 2010 Feb; 451(1-2):23-31. PubMed ID: 19914360
[TBL] [Abstract][Full Text] [Related]
17. Regulation of alternative splicing of tau exon 10.
Qian W; Liu F
Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.
Rodriguez-Martin T; Garcia-Blanco MA; Mansfield SG; Grover AC; Hutton M; Yu Q; Zhou J; Anderton BH; Gallo JM
Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15659-64. PubMed ID: 16230627
[TBL] [Abstract][Full Text] [Related]
19. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta.
Jiang Z; Tang H; Havlioglu N; Zhang X; Stamm S; Yan R; Wu JY
J Biol Chem; 2003 May; 278(21):18997-9007. PubMed ID: 12649279
[TBL] [Abstract][Full Text] [Related]
20. Splicing inhibition of U2AF65 leads to alternative exon skipping.
Cho S; Moon H; Loh TJ; Jang HN; Liu Y; Zhou J; Ohn T; Zheng X; Shen H
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9926-31. PubMed ID: 26216990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
